Ken Griffin Options Holdings

Citadel Advisors LLC

  • $505 Billion
  • Q3 2024

Options Holdings Table

Stock Option Type Value Options Held Last Trade Trade History
Casi Pharmaceuticals Inc
CALL
$0
400
Q3 2024
New holding
Casi Pharmaceuticals Inc
PUT
$0
1.4K
Q3 2024
New holding
CASS
Cass Information Systems Inc

Industrials
CALL
$78,000
1.9K
Q3 2024
Added 363.64%
CASS
Cass Information Systems Inc

Industrials
PUT
$211,000
5.1K
Q3 2024
Added 363.64%
SAVA
Cassava Sciences Inc

Healthcare
CALL
$15.5 Million
527K
Q3 2024
Added 395.18%
SAVA
Cassava Sciences Inc

Healthcare
PUT
$14.5 Million
493K
Q3 2024
Added 395.18%
CSTL
Castle Biosciences Inc

Healthcare
CALL
$1.6 Million
56K
Q3 2024
Added 5800.0%
CSTL
Castle Biosciences Inc

Healthcare
PUT
$168,000
5.9K
Q3 2024
Added 5800.0%
Castor Maritime Inc
CALL
$0
2.5K
Q3 2024
New holding
Castor Maritime Inc
PUT
$0
300
Q3 2024
New holding
CTLT
Catalent, Inc.

Healthcare
PUT
$1.14 Million
18.9K
Q3 2024
Reduced 22.22%
CPRX
Catalyst Pharmaceuticals, Inc.

Healthcare
CALL
$153,000
7.7K
Q3 2024
Added 133.33%
CPRX
Catalyst Pharmaceuticals, Inc.

Healthcare
PUT
$306,000
15.4K
Q3 2024
Added 133.33%
CATY
Cathay General Bancorp

Financial Services
CALL
$279,000
6.5K
Q3 2024
Reduced 52.0%
CATY
Cathay General Bancorp

Financial Services
PUT
$103,000
2.4K
Q3 2024
Reduced 52.0%
CATO
Cato Corp

Consumer Cyclical
CALL
$29,000
6K
Q3 2024
Added 113.86%
CATO
Cato Corp

Consumer Cyclical
PUT
$107,000
21.6K
Q3 2024
Added 113.86%
Cava Group Inc
CALL
$0
1.27M
Q3 2024
Added 38.39%
Cava Group Inc
PUT
$0
1.63M
Q3 2024
Added 38.39%
CVCO
Cavco Industries Inc.

Consumer Cyclical
CALL
$897,000
2.1K
Q3 2024
Reduced 33.33%
CVCO
Cavco Industries Inc.

Consumer Cyclical
PUT
$940,000
2.2K
Q3 2024
Reduced 33.33%
CBAT
Cbak Energy Technology, Inc.

Industrials
CALL
$10,000
8.3K
Q3 2024
Reduced 33.33%
CBAT
Cbak Energy Technology, Inc.

Industrials
PUT
$0
200
Q3 2024
Reduced 33.33%
CBZ
Cbiz, Inc.

Industrials
CALL
$255,000
3.8K
Q3 2024
Added 200.0%
CBZ
Cbiz, Inc.

Industrials
PUT
$20,000
300
Q3 2024
Added 200.0%
CBL
Cbl & Associates Properties Inc

Real Estate
CALL
$2.78 Million
110K
Q3 2024
Reduced 67.35%
CBL
Cbl & Associates Properties Inc

Real Estate
PUT
$120,000
4.8K
Q3 2024
Reduced 67.35%
CBOE
Cboe Global Markets, Inc.

Financial Services
PUT
$19.4 Million
94.8K
Q3 2024
Added 6.68%
CBRE
Cbre Group, Inc.

Real Estate
CALL
$13.9 Million
112K
Q3 2024
Reduced 63.68%
CBRE
Cbre Group, Inc.

Real Estate
PUT
$4.59 Million
36.9K
Q3 2024
Reduced 63.68%
CCCS
Ccc Intelligent Solutions Holdings Inc.

Technology
CALL
$115,000
10.5K
Q3 2024
Reduced 54.17%
CCCS
Ccc Intelligent Solutions Holdings Inc.

Technology
PUT
$12,000
1.1K
Q3 2024
Reduced 54.17%
CDW
Cdw Corp

Technology
CALL
$21.7 Million
95.8K
Q3 2024
Added 138.68%
CDW
Cdw Corp

Technology
PUT
$5.72 Million
25.3K
Q3 2024
Added 138.68%
CECE
Ceco Environmental Corp

Industrials
CALL
$0
17.2K
Q3 2024
Reduced 80.56%
CECE
Ceco Environmental Corp

Industrials
PUT
$0
1.4K
Q3 2024
Reduced 80.56%
CVM
Cel Sci Corp

Healthcare
CALL
$28,000
27.1K
Q3 2024
Added 15.29%
CVM
Cel Sci Corp

Healthcare
PUT
$51,000
49K
Q3 2024
Added 15.29%
CE
Celanese Corp

Basic Materials
CALL
$9.12 Million
67.1K
Q3 2024
Added 143.32%
CE
Celanese Corp

Basic Materials
PUT
$9.16 Million
67.4K
Q3 2024
Added 143.32%
CELC
Celcuity Inc.

Healthcare
CALL
$87,000
5.9K
Q3 2024
New holding
CELC
Celcuity Inc.

Healthcare
PUT
$44,000
3K
Q3 2024
New holding
Celestica Inc
CALL
$0
418K
Q3 2024
Added 102.34%
Celestica Inc
PUT
$0
397K
Q3 2024
Added 102.34%
CLDX
Celldex Therapeutics, Inc.

Healthcare
CALL
$2.85 Million
83.9K
Q3 2024
Added 118.31%
CLDX
Celldex Therapeutics, Inc.

Healthcare
PUT
$1.58 Million
46.5K
Q3 2024
Added 118.31%
CLBT
Cellebrite Di Ltd.

Technology
CALL
$1.52 Million
90K
Q3 2024
Added 86.36%
CLBT
Cellebrite Di Ltd.

Technology
PUT
$69,000
4.1K
Q3 2024
Added 86.36%
Cellectar Biosciences Inc
CALL
$0
33.7K
Q3 2024
Added 17.77%
Ken Griffin

Ken Griffin

Ken Griffin is the founder and CEO of Citadel Advisors, a successful investment firm that uses technology and data-driven approaches to investing. Griffin is known for his expertise in quantitative investing and his innovative approach to investing. He has generated strong returns for his clients over the long term.
Track Ken Griffin's portfolio

Summary

  • Portfolio
  • No. of Stocks 16,902
  • Current Value $505 Billion
  • Prior Value $483 Billion
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 1,111 stocks
  • Additional Purchases 2,227 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 2,336 stocks
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email